Patents Assigned to Mayne Pharma International Pty Ltd
-
Patent number: 11638758Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.Type: GrantFiled: October 19, 2020Date of Patent: May 2, 2023Assignee: MAYNE PHARMA INTERNATIONAL PTY. LTDInventors: Stuart James Mudge, David Hayes, Stefan Lukas
-
Publication number: 20210038728Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.Type: ApplicationFiled: October 19, 2020Publication date: February 11, 2021Applicant: Mayne Pharma International Pty Ltd.Inventors: Stuart James Mudge, David Hayes, Stefan Lukas
-
Patent number: 10869877Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduced side effects such as nausea and irritation.Type: GrantFiled: March 8, 2019Date of Patent: December 22, 2020Assignee: Mayne Pharma International Pty. Ltd.Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
-
Patent number: 10806792Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.Type: GrantFiled: November 1, 2019Date of Patent: October 20, 2020Assignee: Mayne Pharma International Pty Ltd.Inventors: Stuart James Mudge, David Hayes, Stefan Lukas
-
Publication number: 20200138959Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.Type: ApplicationFiled: November 1, 2019Publication date: May 7, 2020Applicant: Mayne Pharma International Pty Ltd.Inventors: Stuart James Mudge, David Hayes, Stefan Lukas
-
Patent number: 10463740Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.Type: GrantFiled: November 21, 2018Date of Patent: November 5, 2019Assignee: MAYNE PHARMA INTERNATIONAL PTY. LTD.Inventors: Stuart James Mudge, David Hayes, Stefan Lukas
-
Publication number: 20190201421Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduced side effects such as nausea and irritation.Type: ApplicationFiled: March 8, 2019Publication date: July 4, 2019Applicant: Mayne Pharma International Pty Ltd.Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
-
Publication number: 20190125879Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.Type: ApplicationFiled: November 21, 2018Publication date: May 2, 2019Applicant: MAYNE PHARMA INTERNATIONAL PTY. LTD.Inventors: Stuart James MUDGE, David HAYES, Stefan LUKAS
-
Patent number: 9713642Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.Type: GrantFiled: October 14, 2015Date of Patent: July 25, 2017Assignee: MAYNE PHARMA INTERNATIONAL PTY. LTD.Inventors: Stuart James Mudge, David Hayes, Stefan Lukas
-
Publication number: 20170182070Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduced side effects such as nausea and irritation.Type: ApplicationFiled: December 5, 2016Publication date: June 29, 2017Applicant: Mayne Pharma International Pty Ltd.Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
-
Patent number: 9511031Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduced side effects such as nausea and irritation.Type: GrantFiled: December 17, 2015Date of Patent: December 6, 2016Assignee: Mayne Pharma International Pty. Ltd.Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
-
Patent number: 9446057Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduce side effects such as nausea and irritation.Type: GrantFiled: November 12, 2015Date of Patent: September 20, 2016Assignee: Mayne Pharma International Pty. Ltd.Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
-
Publication number: 20160263129Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduce side effects such as nausea and irritation.Type: ApplicationFiled: May 23, 2016Publication date: September 15, 2016Applicant: Mayne Pharma International Pty Ltd.Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
-
Patent number: 9295652Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduce side effects such as nausea and irritation.Type: GrantFiled: October 23, 2014Date of Patent: March 29, 2016Assignee: Mayne Pharma International Pty. Ltd.Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
-
Patent number: 9272046Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.Type: GrantFiled: October 10, 2014Date of Patent: March 1, 2016Assignee: MAYNE PHARMA INTERNATIONAL PTY. LTD.Inventors: Stuart James Mudge, David Hayes, Stefan Lukas
-
Patent number: 8921374Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.Type: GrantFiled: June 21, 2013Date of Patent: December 30, 2014Assignee: Mayne Pharma International Pty LtdInventors: Stuart James Mudge, David Hayes, Stefan Lukas
-
Patent number: 8771739Abstract: The present invention provides a pharmaceutical composition of a practically insoluble drug, wherein the composition may be administered with food or without food. The composition may be in the form of a solid dispersion of the practically insoluble drug and a polymer having acidic functional groups, and the composition may in vitro form a suspension.Type: GrantFiled: June 15, 2007Date of Patent: July 8, 2014Assignee: Mayne Pharma International Pty LtdInventors: David Hayes, Angelo M. Morella
-
Publication number: 20140127291Abstract: Disclosed herein is an extended release liquid pharmaceutical composition comprising extended release particles dispersed in a liquid medium. The extended release particles comprise acetaminophen dispersed or encapsulated in a water insoluble polymer and/or wax to provide an extended release dosage form of acetaminophen. The liquid medium comprises water, an active pharmaceutical ingredient in immediate release form and, optionally, excipients. The composition is storage stable for at least 6 months at 40° C. and 75% relative humidity.Type: ApplicationFiled: January 25, 2012Publication date: May 8, 2014Applicant: MAYNE PHARMA INTERNATIONAL PTY LTDInventor: Angelo Mario Morella
-
Patent number: 8715724Abstract: A process for producing a compressed solid dosage form containing an active ingredient. The process includes a step of preparing core elements containing the active ingredient. Optionally the core elements are coated with a pharmaceutically acceptable coating layer to form coated pellets. The core elements or pellets are treated with an anti-static agent and compressed with suitable excipients to form the compressed solid dosage form. Preferred anti static agents are starch, microcrystalline cellulose, kaolin, bentonite, silicates, silicon dioxide, cellulose, stearic acid, sodium stearyl fumarate and glyceryl behenate.Type: GrantFiled: October 28, 2005Date of Patent: May 6, 2014Assignee: Mayne Pharma International Pty LtdInventor: Stefan Lukas
-
Publication number: 20140005205Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.Type: ApplicationFiled: June 21, 2013Publication date: January 2, 2014Applicant: Mayne Pharma International Pty. Ltd.Inventors: Stuart James MUDGE, David Hayes, Stefan Lukas